Investment
Features
FeesSafety
Academy
More
Pluang+

Compare BioNano Genomics Inc (BNGO) vs Monolithic Power Systems Inc (MPWR) Price & Performance

BioNano Genomics IncTrade
Monolithic Power Systems IncTrade

Price performance (Past 24H)

Key statistics

BioNano Genomics Inc vs Monolithic Power Systems Inc — how do they compare? BioNano Genomics Inc trades at $1.18 (market cap $13.20M), while Monolithic Power Systems Inc trades at $1,332.93 (market cap $67.62B). The key difference: Monolithic Power Systems Inc is far larger — about 5122.7× BioNano Genomics Inc's market cap, and Monolithic Power Systems Inc pays a 0.58% dividend while BioNano Genomics Inc pays none. Which is the better fit depends on your goals.

BNGOMPWR
Market Cap
$13.20M$67.62B
Sector
HealthUtilities
52-Week High
$4.92$1.69K
52-Week Low
$1.09$711.24
Enterprise Value
$15.81M$66.28B
Dividend Yield
0.58%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

BioNano Genomics Inc

Bionano Genomics (BNGO) trades at $1.17, down 2.5% today, but maintains a bullish technical signal with strong moving average support. The company shows improving fundamentals with revenue stabilizing around $29M annually and narrowing losses, though it remains unprofitable with a -109.95% net margin. Recent positive developments include debt retirement and growing adoption of optical genome mapping technology.

BNGO presents a high-risk, high-reward opportunity with analyst consensus leaning bullish (57% buy ratings). The stock trades at attractive valuation multiples (P/S 0.31, P/B 0.36) but faces execution risks in achieving profitability. Key catalysts include continued technology adoption and potential margin improvement, while persistent losses and competitive pressures remain concerns.

Monolithic Power Systems Inc

Monolithic Power Systems (MPWR) trades at $1,291.38, down 4.54% on the day, amid a bearish technical signal despite strong fundamentals. The stock shows robust profitability with 22.98% net income margin and has beaten earnings estimates for three consecutive quarters. Analyst consensus remains strongly bullish with 88% buy ratings and a $1,760 price target, representing significant upside potential from current levels.

The stock presents a compelling growth opportunity driven by AI infrastructure demand and power semiconductor trends, though elevated valuation multiples and ongoing legal investigations pose risks. Technical indicators suggest near-term weakness, but strong institutional support and consistent earnings performance support the long-term bullish case for investors seeking exposure to semiconductor growth.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About BioNano Genomics Inc

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.

Read more on BNGO

About Monolithic Power Systems Inc

Monolithic Power Systems, Inc. is a global leader in high-performance, analog, and mixed-signal semiconductors. The company specializes in power management solutions, providing integrated circuits (ICs) for a wide range of applications, including computing, automotive, industrial, and communications. MPWR's proprietary process technology is designed to deliver highly energy-efficient and compact power solutions, positioning the company as a key supplier for the next generation of electronic devices.

Read more on MPWR